WHO ICTRP trial
Study to evaluate the safety, tolerability, and effect of the body and food on…
ISRCTN63295298 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN63295298 |
|---|---|
| Public title | Study to evaluate the safety, tolerability, and effect of the body and food on RO7308480 following oral administration in healthy participants |
| Scientific title | A Phase I randomized, investigator/participant-blind, adaptive, single ascending dose, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics, and food effects of RO7308480 following oral administration in healthy participants |
| Primary sponsor | F. Hoffmann-La Roche Ltd |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase I |
| Countries | France |
| Conditions | Safety, tolerability, pharmacokinetics, and food effects of single-ascending oral doses of RO7308480 in healthy participants Not Applicable |
| Interventions | Part 1: RO7308480-SAD Cohorts: Participants will receive a single dose of RO7308480 capsule, orally, under fasted conditions on Day 1 in cohort 1. The dose will be escalated in subsequent cohorts in six steps as per the Sponsor’s clinical… |
| Registration date | Nov 2, 2022 |
| Target size | 96 |
| Secondary IDs | 2021-004128-13;Nil known;BP43318 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: